Most Recent
Samsung Bioepis takes aim at patents for eye disease biosimilar
Intellectual Property 2023-11-09 11:23 pm By Cat Fredenburgh

South Korean biosimilars company Samsung Bioepis has sued to invalidate two patents held by a German competitor for a pre-filled syringe to treat age-related eye diseases, as generic drug makers race for a piece of the lucrative eye drug market.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Class action investigation targets Exactech over implants
Product Liability 2023-11-08 2:53 pm By Christine Caulfield

An investigation is underway against US medical device maker Exactech on behalf of patients who allegedly received faulty hip, knee or ankle implants.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

OAIC takes Australian Clinical Labs to court over data breach
Privacy & Cybersecurity 2023-11-03 3:14 pm By Cindy Cameronne

The Office of the Australian Information Commissioner has brought civil penalty proceedings accusing pathology services provider Australian Clinical Labs of failing to take steps to prevent a February 2022 data breach that affected millions of patients.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Bayer defeats Sandoz challenge to patents for blood thinner Xarelto
Intellectual Property 2023-11-02 9:41 pm By Cindy Cameronne

Novartis unit Sandoz AG has lost its bid to revoke Bayer’s patents for its top-selling blood clot drug Xarelto and has been barred from selling generic versions of the medication after a judge found the German pharma giant’s patents were valid.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Victorian healthcare providers stung with junior doctors class action
Employment 2023-10-23 10:44 pm By Cat Fredenburgh

Two more Victorian healthcare providers have been hit with a class action on behalf of junior doctors alleging they were not paid for unrostered work.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Healthcare industry more vulnerable to cyberattacks, says Wotton + Kearney partner
Privacy & Cybersecurity 2023-10-23 6:17 pm By Cindy Cameronne

The digitisation of healthcare has left the industry particularly vulnerable to cyberattacks, and protecting consumers from breaches is one of the biggest challenges facing the sector, according to a new health law partner at Wotton + Kearney. 

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

‘What’s the limit to this?’ Judge questions bid for insurance docs in COVID-19 outbreak class actions
Insurance 2023-10-19 9:15 pm By Sam Matthews

A judge has questioned a challenge by two class actions against Victorian aged care providers to a ruling that rejected their bid for insurance and financial information, which the defendants argue would have far-reaching implications.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Publishers hit with defamation suits over ‘Medicare scandal’ reports
Defamation 2023-10-17 3:26 pm By Sam Matthews

Two cosmetic surgeons have filed defamation suits seeking aggravated damages over coverage by the ABC and Fairfax that allegedly painted them as “outlaw surgeons” who mutilated a patient and exploited the Medicare system.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Monash Health wins appeal over ‘sham’ restructure of library services
Appeals 2023-10-17 10:03 pm By Cindy Cameronne

Monash Health has won its challenge to a decision finding it wrongfully dismissed a librarian in a ‘sham’ redundancy.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Class action investigation underway into Cipro antibiotic
Class Actions 2023-10-11 3:30 pm By Sam Matthews

An Australian law firm is investigating a class action against drug manufacturers over a commonly prescribed antibiotic said to cause “disabling” side effects, including nerve damage and psychosis.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?